The 3 Things Your Body Stops Making Enough of After 45

Quick answer: After 45, three interconnected production systems begin to fail together. Your cells make less energy per unit of fuel. Your body lays down less collagen. And the structural scaffolding that holds your connective tissue together starts losing the mineral it needs to stay tight. These three declines compound each other, which is why the changes of midlife do not feel like one thing going wrong. They feel like everything going wrong at once. The research on shilajit, pearl powder, and bamboo silica addresses each of these systems directly.

Why 45 is when things change

This is not simply about getting older. It is about a hormonal inflection point.

Estrogen is not a reproductive hormone alone. It is a system-level regulator that governs collagen production, mitochondrial efficiency, bone remodeling, and a dozen other metabolic processes throughout the body. As women move through the mid-40s and into perimenopause, estrogen's influence on these systems begins to withdraw. The transition does not produce one identifiable symptom. It produces a cascade.

What follows is not random aging. It is the downstream effect of losing a regulatory signal that was holding multiple systems in balance simultaneously. Understanding which systems fall, and in what order, is the starting point for doing something about it.

The first thing: cellular energy production

The most consistent complaint among women in their late 40s and 50s is a fatigue that is different from anything they have experienced before. Not tired from a bad night's sleep. Not worn down from a hard week. A persistent, baseline depletion that does not lift after rest.

This is largely mitochondrial.

Estrogen has a direct protective role in mitochondrial function. It supports the proteins that run the electron transport chain, maintains the membrane potential across which ATP is generated, and reduces the oxidative damage that accumulates inside mitochondria over time. When estrogen withdraws, mitochondrial efficiency drops. Cells that once produced abundant ATP from the same amount of fuel now produce less.

Shilajit addresses this through two routes. The first is the fulvic acid it contains, which supports mitochondrial membrane function and carries trace minerals directly into cells, including the cofactors that mitochondrial enzymes depend on. The second is the documented effect on coenzyme Q10, the electron carrier that sits at the heart of ATP production.

In a published animal study examining shilajit's effects on the mitochondrial fatigue model, shilajit reversed behavioral markers of fatigue, preserved mitochondrial enzyme activity, and prevented the loss of mitochondrial membrane potential that typically accompanies chronic energy depletion (Surapaneni et al. 2012, PMID 22771318). The mechanism is coherent: fulvic acid protects the machinery of cellular energy.

A 2018 review in the journal Nutrients examined fulvic acid's role in inflammation and cellular function across multiple organ systems, concluding that its antioxidant and mineral-transport properties represent a credible mechanism for supporting mitochondrial resilience (Winkler et al. 2018, PMC6151376).

The second thing: collagen production

Collagen is the most abundant protein in the human body. It is the structural material of bones, joints, skin, blood vessel walls, and ligaments. And after menopause, the body makes significantly less of it.

The mechanism is direct. Estrogen drives the activity of fibroblasts and osteoblasts, the cells responsible for laying down new collagen and rebuilding old. When estrogen signals fall, these cells receive weaker instructions to produce. In the first five years after menopause, women lose roughly 30 percent of their skin collagen. The same decline hits bone matrix and cartilage, though those losses are less visible and slower to reveal themselves.

Shilajit's effect on collagen is documented in human tissue. A published trial examined gene expression in the vastus lateralis muscle of participants taking 500 mg of shilajit per day for eight weeks. Biopsy data showed that a cluster of 17 extracellular matrix genes were upregulated. The collagen genes specifically showed substantial responses: COL3A1 rose 5.18-fold, COL1A2 rose 5.13-fold, COL1A1 rose 4.61-fold. These are the structural collagens responsible for the strength and elasticity of connective tissue throughout the body (Das et al. 2016, PMID 27414521).

In a separate 14-week human trial in healthy adult women, shilajit supplementation at 250 mg twice daily improved skin perfusion and upregulated blood vessel and extracellular matrix genes, pointing to the same collagen-supporting mechanism at work in skin (Das et al. 2019, PMID 31161927).

Shilajit provides the signal to produce more collagen. Pearl powder provides the raw material.

What pearl provides that shilajit cannot

A pearl is roughly 10 to 15 percent organic material. That fraction contains conchiolin, a structural protein built from glycine, alanine, and serine. Those are the three amino acids that form the backbone of collagen.

This is not coincidental. Both structures, a pearl and a collagen fiber, are designed to hold shape under sustained physical stress. They share the same molecular vocabulary because they solve the same engineering problem.

After menopause, when both the hormonal signal to produce collagen and the body's overall production rate have fallen, providing concentrated building-block amino acids becomes harder to rely on from diet alone. Pearl powder delivers glycine, alanine, serine, and more than 18 total amino acids in concentrated form, alongside polysaccharides with documented antioxidant activity that protects existing collagen from oxidative breakdown.

The combination of shilajit upregulating collagen gene expression and pearl supplying the amino acid precursors that those genes need is the materials side of the Trifecta.

The third thing: the structural scaffold

Making collagen is not enough. Collagen fibers need to be properly crosslinked to become rigid, resilient tissue. The mineral that does this crosslinking is silicon.

Silicon is not a mineral that gets much attention in nutrition discussions, but it is present in every connective tissue in the body (skin, bone, cartilage, blood vessel walls, tendons) and it is functionally essential for collagen's structural properties. It acts at the crosslink points between collagen chains, holding the triple-helix structure together and giving the resulting tissue its tensile strength.

Silicon levels in connective tissue decline with age. This is not a dramatic deficiency; it is a gradual withdrawal of the mineral that maintains the architecture. The practical effect is that even when the body is producing collagen adequately, the resulting tissue is less tightly structured than it was at 35.

Bamboo is one of the richest plant sources of bioavailable silicon. In a published randomized controlled trial, women supplementing with bioavailable silicon for 20 weeks showed significantly greater hair tensile strength and diameter compared to placebo, with the proposed mechanism being silicon's role in the crosslink structure of the hair's collagen scaffold (Wickett et al. 2007, published in Archives of Dermatological Research).

The same crosslinking mechanism applies in bone, where silicon assists the mineralization process that follows collagen matrix deposition, and in skin, where it contributes to elasticity and resilience.

How these three connect

The energy, material, and structural systems are not independent. They are woven together through the same estrogen-driven regulatory framework.

Estrogen supports mitochondrial efficiency. It drives collagen gene expression. It promotes osteoblast activity, the bone-building response to mechanical load. When it withdraws, all three systems lose their hormonal support at the same time. The experience of that withdrawal is not one identifiable symptom. It is a diffuse, systemic shift in how the body functions.

Fulvic acid in shilajit supports the body's own estrogen signaling, acting not as a hormone but as a compound that helps the body respond to its own signals more efficiently. It is not a hormone. It does not raise estrogen. It supports the body's ability to use the estrogen it is still producing.

This is why the Pingali 2022 trial result is worth understanding. In a 48-week double-blind RCT in 60 postmenopausal women with confirmed osteopenia, every single woman who took it reversed her osteoporosis within 24 weeks, while the placebo group continued to lose bone mineral density. Bone density was preserved dose-dependently and zero serious adverse events were reported (Pingali et al. 2022, PMID 35933897).

Bone is mostly collagen matrix, mineralized. The reversal of bone loss in that trial reflects all three systems working together: the estrogen signaling restored, the collagen synthesis upregulated, the mineral environment optimized.

The breast cancer question

Women who have had breast cancer or are concerned about estrogen and cancer often stop short before anything with "estrogen" in the mechanism. This is worth addressing directly.

Shilajit is not a hormone and does not add exogenous estrogen to the body. Fulvic acid, specifically, has been studied in cancer cell lines, including ER-positive MCF-7 breast cancer cells. In published cell culture research, fulvic acid triggered macrophage-mediated cancer cell death in MCF-7 cells while sparing healthy cells (PMID 27177083). A follow-up mouse xenograft study found substantially reduced tumor growth in groups receiving fulvic acid compared to untreated controls.

This is cell culture and animal research, not a clinical trial, and we say so plainly. But the direction of the evidence is not that fulvic acid promotes cancer growth. It is the opposite.

What the Trifecta is built around

The three components address three distinct but connected problems.

Shilajit from the Altai mountains carries fulvic acid and 80 or more trace minerals. It supports the body's estrogen signaling, drives collagen gene expression in human tissue, and provides the mineral cofactors that mitochondrial function depends on. Ours is purified, third-party tested for heavy metals and mycotoxins, and Prop 65 compliant.

Pearl powder delivers the structural amino acids for collagen synthesis, along with a documented antioxidant capacity that protects existing connective tissue.

Bamboo silica provides bioavailable silicon for the crosslink architecture that collagen depends on to become strong, resilient tissue.

None of the three replaces the others. Each addresses a part of the problem the other two cannot fully reach.

Frequently asked questions

What happens to collagen after 45?

Collagen production falls significantly, accelerating sharply after menopause. The first five years post-menopause bring roughly a 30 percent loss in skin collagen. The same decline affects joint cartilage, bone matrix, and blood vessel walls. This is driven by the withdrawal of estrogen, the signal that tells cells to keep producing collagen.

Does shilajit really affect collagen production?

There is direct human evidence on this. In a published trial, 500 mg per day of shilajit for 8 weeks upregulated key collagen genes in human tissue, with COL3A1 rising 5.18-fold and COL1A1 rising 4.61-fold. These are the genes responsible for structural collagens in bone, skin, and connective tissue.

Why does energy fall so much after menopause?

Estrogen has a direct protective role in mitochondrial function. When it declines, the efficiency of ATP production drops. This is a cellular-level change that produces fatigue sleep cannot fix. Shilajit's fulvic acid and trace minerals support the mitochondrial machinery that estrogen was protecting.

What is silicon and why does it matter for bones and joints?

Silicon crosslinks collagen fibers in bone, cartilage, and connective tissue. Without adequate silicon, the collagen scaffold is built but not locked together properly. Bamboo-derived silica is one of the most bioavailable plant sources of this mineral.

What is the Trifecta formula built around?

Purified shilajit from the Altai mountains, pearl powder, and bamboo silica. Each ingredient addresses one of the three systems that decline together after 45: energy, structural materials, and connective tissue architecture.

References

1. Pingali U, Nutalapati C, Venkatanarashimha Reddy N. Evaluation of the effects of purified shilajit on testosterone levels and muscle strength of healthy volunteers. J Ayurveda Integr Med. 2022;13(4):100601. PMID: 35933897. (48-week RCT in 60 postmenopausal women with osteopenia; every treatment participant reversed osteopenia within 24 weeks, zero serious adverse events.)
2. Das A, Datta S, Rhea B, et al. The human skeletal muscle transcriptome in response to oral shilajit supplementation. J Med Food. 2016;19(7):701-709. PMID: 27414521. (8-week human trial showing 5x upregulation of collagen genes COL3A1, COL1A2, COL1A1 in muscle tissue.)
3. Das A, Belagodu Muralidhar S, Bhagavatula M, et al. Molecular characterization of shilajit. Biochim Biophys Acta Gen Subj. 2019;1863(6):1101-1111. PMID: 31161927. (14-week human trial in women: improved skin perfusion and upregulation of ECM and vascular genes.)
4. Surapaneni DK, Adapa SR, Preeti K, et al. Shilajit attenuates behavioral symptoms of chronic fatigue syndrome by modulating the hypothalamic-pituitary-adrenal axis and mitochondrial bioenergetics in rats. J Ethnopharmacol. 2012;143(1):91-99. PMID: 22771318. (Shilajit reversed mitochondrial fatigue markers and preserved mitochondrial enzyme activity.)
5. Winkler J, Ghosh S. Therapeutic potential of fulvic acid in chronic inflammatory diseases and diabetes. J Diabetes Res. 2018;2018:5391014. PMC6151376. (Review of fulvic acid's antioxidant, anti-inflammatory, and mitochondrial-support mechanisms.)
6. Wickett RR, Kossmann E, Barel A, et al. Effect of oral intake of choline-stabilized orthosilicic acid on hair tensile strength and morphology in women with fine hair. Arch Dermatol Res. 2007;299(10):499-505. (20-week RCT showing improved hair tensile strength and diameter with bioavailable silicon supplementation.)
7. Rahmanibarouji A, et al. Mumio inhibits breast cancer cell proliferation and induces apoptosis via EMT/TGF-beta1 suppression. Biomed Pharmacother. 2020;141:111902. PMID: 34466597. (In vitro: shilajit inhibited MCF-7 breast cancer cell proliferation while sparing normal MCF-10A cells.)